Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoreactive mechanisms in infective endocarditis.

B Maisch1

  • 1Department of Internal Medicine-Cardiology, Philipps-University Marburg, Federal Republic of Germany.

Springer Seminars in Immunopathology
|January 1, 1989
PubMed
Summary

Infective endocarditis involves immune system dysfunction, including decreased T cell and natural killer cell activity. Treatment normalizes immune responses and may reduce heart failure risk from anti-heart antibodies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[2019 ESC guidelines: consensus in Europe for 25 years].

Herz·2019
Same author

[The 4 R of the ESC guidelines 2018: relevance, redundancy, reality, and relativization].

Herz·2018
Same author

[Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis].

Herz·2018
Same author

Heart failure 2.0 or 0.1?

Herz·2018
Same author

Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.

Herz·2018
Same author

[ESC guidelines 2017 : What is new and what is of particular importance?]

Herz·2017

Area of Science:

  • Immunology
  • Cardiology
  • Infectious Diseases

Background:

  • Infective endocarditis (IE) pathogenesis extends beyond microbial invasion, involving host immune responses.
  • Predisposition to IE may involve impaired T cell suppressor activity.
  • Cardiac valve vegetation can trigger complex immune reactions.

Purpose of the Study:

  • To investigate the immunological alterations in patients with infective endocarditis.
  • To assess the impact of antimicrobial therapy on immune cell activity and immune complexes.
  • To explore the role of autoantibodies in the cardiac manifestations of IE.

Main Methods:

  • Analysis of peripheral blood natural killer (NK) cell activity.
  • Assessment of non-major histocompatibility complex-restricted lymphocytotoxicity against heart cells.
  • Measurement of circulating immune complexes.
  • Detection of anti-bacterial and anti-sarcolemmal antibodies.

Main Results:

  • Decreased peripheral blood NK cell activity during infection, normalizing with antimicrobial therapy.
  • Presence of lymphocytotoxicity to heart cells in a subset of patients.
  • Circulating immune complexes normalized during therapy and may contribute to clinical symptoms.
  • Polyclonal immune response includes anti-bacterial and cross-reactive anti-sarcolemmal antibodies.

Conclusions:

  • Infective endocarditis is associated with significant immune dysregulation.
  • Antimicrobial therapy can restore immune balance.
  • Anti-sarcolemmal antibodies may contribute to heart failure in IE patients, particularly with pre-existing valve issues.

Related Experiment Videos